Upgrading Monocytes Therapy for Critical Limb Ischemia Patient Treatment: Pre-Clinical and GMP-Validation Aspects

Advanced cell therapy medicinal products (ATMP) are at the forefront of a new range of biopharmaceuticals. The use of ATMP has evolved and increased in the last decades, representing a new approach to treating diseases that are not effectively managed with conventional treatments. The standard world...

Descripción completa

Detalles Bibliográficos
Autores principales: Rusconi, Giulio, Cusumano, Giuseppe, Mariotta, Luca, Canevascini, Reto, Gola, Mauro, Gornati, Rosalba, Soldati, Gianni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604444/
https://www.ncbi.nlm.nih.gov/pubmed/36293525
http://dx.doi.org/10.3390/ijms232012669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604444/
https://www.ncbi.nlm.nih.gov/pubmed/36293525
http://dx.doi.org/10.3390/ijms232012669

Ejemplares similares